We’re proud to be sharing our research at AASLD The Liver Meeting in Washington, D.C. (7–11 November)!

Visit us at #AASLD2024 at Booth #726 to learn how Perspectum is advancing imaging biomarkers and AI tools for liver disease research and clinical care.

#Perspectum #AASLD25

Preclinical data suggests functional cure for HBV - Drug Discovery World (DDW) Epigenome editing company Tune Therapeutics has showcased new data at the American Association for the Study of Liver Diseases (AASLD) conference, in support of its drive to develop a lasting, functio...

Featured in Drug Discovery World - At #AASLD2024, Principal Scientist Brian Cosgrove unveiled new data on Tune-401, their liver-targeting LNP-RNA epi-silencing drug. www.ddw-online.com/preclinical-... #HBV #Epigenetics